PHG NYSE
Credit Risk of going bust: lower than 71% of companies Debt: 24.4% of company value Bonds: $54.1M held by 58 funds, 101 bp over Treasuries → details ▾
Total debt $8.31B against a stock market value of $25.80B.
Distance to default 7.76 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $4.79B (short-term plus half of long-term), stock volatility 28.2%; Altman Z'' 2.10. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Amsterdam, NH 1077 WV
NL
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.
